ZANTAC CANCER LAWSUITS
Zantac (Ranitidine) Cancer
The Firm is reviewing claims on behalf of Zantac users who have since been diagnosed with cancer.
Like millions of other heartburn sufferers out there, you might have relied on Zantac – or its generic equivalents sold as “Ranitidine” under drug store brands like Walmart’s Equate brand or CVS’s Health Store – get through the day. Now that research has linked the drug to a variety of cancers, the government has ordered it pulled from the shelves and former users diagnosed with cancer are left trying to pick up the pieces.
Studies link cancer to Zantac because of the reported contamination of the drug by a chemical called N-Nitrosodimethylamine (NDMA). Agencies such as the U.S. Food and Drug Administration (FDA) and the Environmental Protection Agency (EPA) consider NDMA a “probable human carcinogen.” Usually, NDMA is found at low, harmless levels in drugs. However, NDMA was found in Zantac and its generic equivalents at levels beyond what is considered safe.
Based on this research, the FDA recently announced a recall of Zantac along with all other medications using its active ingredient, Ranitidine.
According to the U.S. Centers for Disease Control (CDC), NDMA has been linked to a variety of diseases, including severe liver disease, liver cancer, and lung cancer. Millions of people used Zantac for years not knowing about the risks they were exposing themselves to, and some users are now suffering from cancer that may have been caused by the drug.
Zantac’s manufacturer, Sanofi, and other manufacturers of Ranitidine medications like Mylan Pharmaceuticals, Glenmark, and Northwind, had a responsibility to ensure that their customers wouldn’t suffer injury from using their product, and they have failed to meet that responsibility.
Zantac users who have been diagnosed with cancer after using the drug deserve compensation, and we want to help them get it. If you or a loved one was diagnosed with cancer after using Zantac, give us a call today for a free consultation. You may be eligible for compensation.
A Growing Danger
The investigation into NDMA contamination of Ranitidine began in 2019. After Valisure, an independent lab, found some evidence of contamination, the FDA and the sellers of Zantac announced a voluntary recall. Zantac was taken off shelves in many places, and people were advised to stop using it until further notice.
But as the evidence mounted, the FDA was forced to issue a full recall in April 2020. Researchers observed that as stock of Ranitidine sat in storage, the NDMA contamination increased. The longer it sat, and the hotter the temperature they were stored in, the worse the contamination got.
The list of illnesses potentially associated with the consumption of NDMA-contaminated products includes:
At this time, we don’t know how long this dangerous chemical has been contaminating a product that millions of people used every day to treat their heartburn symptoms. Nor do we know how many people have suffered severe health problems as a result.
History Of Voluntary Recall
The FDA mandatory recall of Zantac/Ranitidine is only the final step in a process that began in September 2019 with the voluntary recall by Sandoz Inc. and the Apotex Corporation of their Ranitidine products. Between then and the mandatory recall in April 2020, at least 16 brands voluntarily removed their Zantac/Ranitidine products from the shelves, including:
Sandoz Inc - Ranitidine Hydrochloride Capsules
Apotex Corporation - Ranitidine Tablets
American Health Packaging - Ranitidine Tablets
Mylan Pharmaceuticals Inc. - Nizatidine Capsules
Northwind - Ranitidine Tablets 150mg and 300mg
ani - Ranitidine Tablets 150mg and 300mg
Glenmark - Ranitidine Tablets 150mg and 300mg
Amneal - Ranitidine Tablets and Ranitidine Syrup
PrecisionDose - Ranitidine Oral Solution
GSMS Incorporated - Ranitidine HCl 150mg and 300mg Capsules
AHP - Ranitidine Liquid Unit Dose Cups
Aurobindo & DG Health - Ranitidine Tablets
Novitium Pharma - Ranitidine Hydrochloride Capsules
Lannett Company, Inc. - Ranitidine Syrup
Dr. Reddy's - Ranitidine Tablets & Capsules
Sanofi - Zantac 150, Zantac 150 Cool Mint, Zantac 75
Perrigo Company plc - Ranitidine tablets
Holding Them Accountable
Zantac’s manufacturers didn’t do enough to keep their customers safe, and they need to be held accountable for their negligence and the damage they’ve caused. If you or a loved one was diagnosed with cancer after using Zantac, justice and compensation could be within reach. Call us today for a free consultation. You don’t pay anything unless we win your case.
Contact us today. Weready to get started fighting for you.